The Influence of Release Modifier Differences in Formulations on the Pharmacokinetic Profile of Ketoprofen in Rats: A Scoping Review

Adi Yugatama, Alyanis Mufid SWM, Rasmaya Niruri, Ya-Lin Huang, Nguyen Dang Khoa

Abstract

The pharmacokinetic profile of drugs can be changed by genetic, environmental, and physiological variables such as age, sex, pregnancy, and different preparations and formulations. Ketoprofen is widely used in many different preparations and formulations. The various formulations can made by adding solubilizing and extending release agents. This study aimed to determine the influence of formulation differences on the pharmacokinetic profile of ketoprofen in rats. This research was a Literature Review. Articles were retrieved from the ScienceDirect and PubMed databases from 2011 to 2020. The inclusion criteria were the research article, the presence of ketoprofen was formulated with the addition of a solubilizing or extended-release agent, given orally and available in open access. The study resulted in differences in formulation, notably the addition of various dissolving agents or extended-release agents, which caused changes in the pharmacokinetic profile of ketoprofen. The highest increase in the pharmacokinetic parameters Cmax and AUC of ketoprofen was observed with poloxamer-188 as a release modifier agent. Therefore, the use of release modifier agents could have a significant effect on the drug's pharmacokinetic profile.

Full Text:

PDF

References

Abou-Taleb, H. A., Shoman, M. E., Makram, T. S., Abdel-Aleem, J. A., & Abdelkader, H. (2023). Exploration of the safety and solubilization, dissolution, analgesic effects of common basic excipients on the NSAID drug ketoprofen. Pharmaceutics, 15(2). 10.3390/PHARMACEUTICS15020713.

Adepu, S., & Ramakrishna, S. (2021). Controlled drug delivery systems: current status and future directions. Molecules, 26(19). 10.3390/MOLECULES26195905.

Anil, A., Kaya, F. N., Yavaşcaoǧlu, B., Mercanoǧlu Efe, E., Türker, G., & Demirci, A. (2016). Comparison of postoperative analgesic efficacy of intraoperative single-dose intravenous administration of dexketoprofen trometamol and diclofenac sodium in laparoscopic cholecystectomy. Journal of Clinical Anesthesia, 32, 127–133. 10.1016/J.JCLINANE.2016.02.020.

Carbone, C., Rende, P., Comberiati, P., Carnovale, D., Mammì, M., & De Sarro, G. (2013). The safety of ketoprofen in different ages. Journal of Pharmacology & Pharmacotherapeutics, 4(Suppl1), S99. 10.4103/0976-500X.120967.

Chiappisi, L. (2017). Polyoxyethylene alkyl ether carboxylic acids: An overview of a neglected class of surfactants with multiresponsive properties. Advances in Colloid and Interface Science, 250, 79–94. 10.1016/J.CIS.2017.10.001.

Das, S. K., Chakraborty, S., Bose, A., Rajabalaya, R., & Khanam, J. (2021). Effects of the preparation technique on the physicochemical characteristics and dissolution improvement of ketoprofen-SBE7-β-CD binary inclusion complexes. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 611, 125775. 10.1016/J.COLSURFA.2020.125775.

De Stefani, C., Lodovichi, J., Albonetti, L., Salvatici, M. C., Quintela, J. C., Bilia, A. R., & Bergonzi, M. C. (2022). Solubility and permeability enhancement of oleanolic acid by solid dispersion in poloxamers and γ-CD. Molecules, 27(9). 10.3390/MOLECULES27093042/S1.

Diaz-Reval, M. I., Ventura-Martinez, R., Hernandez-Delgadillo, G. P., Dominguez-Ramirez, A. M., & Lopez-Munoz, F. J. (2001). Effect of caffeine on antinociceptive action of ketoprofen in rats. Archives of Medical Research, 32(1), 13–20. 10.1016/S0188-4409(00)00268-X.

Fan, J., & De Lannoy, I. A. M. (2014). Pharmacokinetics. Biochemical Pharmacology, 87(1), 93–120. 10.1016/J.BCP.2013.09.007.

Fischer, S. M., Parmentier, J., Buckley, S. T., Reimold, I., Brandl, M., & Fricker, G. (2012). Oral bioavailability of ketoprofen in suspension and solution formulations in rats: the influence of poloxamer 188. The Journal of Pharmacy and Pharmacology, 64(11), 1631–1637. 10.1111/J.2042-7158.2012.01541.X.

Fox, C. B., Cao, Y., Nemeth, C. L., Chirra, H. D., Chevalier, R. W., Xu, A. M., Melosh, N. A., & Desai, T. A. (2016). Fabrication of sealed nanostraw microdevices for oral drug delivery. ACS Nano, 10(6), 5873. 10.1021/ACSNANO.6B00809.

Gaskell, H., Derry, S., Wiffen, P. J., & Moore, R. A. (2017). Single dose oral ketoprofen or dexketoprofen for acute postoperative pain in adults. The Cochrane Database of Systematic Reviews, 5(5). 10.1002/14651858.CD007355.PUB3.

Gazal, G., & Al-Samadani, K. H. (2017). Comparison of paracetamol, ibuprofen, and diclofenac potassium for pain relief following dental extractions and deep cavity preparations. Saudi Medical Journal, 38(3), 284–291. 10.15537/SMJ.2017.3.16023.

Hooijmans, C. R., Rovers, M. M., De Vries, R. B. M., Leenaars, M., Ritskes-Hoitinga, M., & Langendam, M. W. (2014). SYRCLE’s risk of bias tool for animal studies. BMC Medical Research Methodology, 14(1). 10.1186/1471-2288-14-43.

Kuczynska, J., & Nieradko-Iwanicka, B. (2022). New uses of ketoprofen - a review of studies from 2015 to 2021. Current Issues in Pharmacy and Medical Sciences, 35(1), 16–20. 10.2478/CIPMS-2022-0004.

Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine, 6(7). 10.1371/JOURNAL.PMED.1000100.

Malkawi, R., Malkawi, W. I., Al-Mahmoud, Y., & Tawalbeh, J. (2022). Current trends on solid dispersions: past, present, and future. Advances in Pharmacological and Pharmaceutical Sciences, 2022. 10.1155/2022/5916013.

Mariniello, D. F., Allocca, V., D’Agnano, V., Villaro, R., Lanata, L., Bagnasco, M., Aronne, L., Bianco, A., & Perrotta, F. (2022). Strategies tackling viral replication and inflammatory pathways as early pharmacological treatment for SARS-CoV-2 infection: any potential role for ketoprofen lysine salt?. Molecules, 27(24), 8919. 10.3390/MOLECULES27248919.

Mazzoni, C., Tentor, F., Strindberg, S. A., Nielsen, L. H., Keller, S. S., Alstrøm, T. S., Gundlach, C., Müllertz, A., Marizza, P., & Boisen, A. (2017). From concept to in vivo testing: Microcontainers for oral drug delivery. Journal of Controlled Release: Official Journal of the Controlled Release Society, 268, 343–351. 10.1016/J.JCONREL.2017.10.013.

Methley, A. M., Campbell, S., Chew-Graham, C., McNally, R., & Cheraghi-Sohi, S. (2014). PICO, PICOS, and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Services Research, 14(1). 10.1186/S12913-014-0579-0.

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., Antes, G., Atkins, D., Barbour, V., Barrowman, N., Berlin, J. A., Clark, J., Clarke, M., Cook, D., D’Amico, R., Deeks, J. J., Devereaux, P. J., Dickersin, K., Egger, M., Ernst, E., Gøtzsche, P. C., … Tugwell, P. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine, 6(7). 10.1371/JOURNAL.PMED.1000097.

Moloughney, J. G., & Weisleder, N. (2012). Poloxamer 188 (P188) as a membrane resealing reagent in biomedical applications. Recent Patents on Biotechnology, 6(3), 200. 10.2174/1872208311206030200.

Munir, R., Hadi, A., Khan, S. U. D., Asghar, S., Irfan, M., Khan, I. U., Hameed, M., Inam, S., Islam, N., Hassan, S. F., Ishtiaq, M., Shah, P. A., Iqbal, M. S., Syed, H. K., Khames, A., & Abourehab, M. A. S. (2022). Solubility and dissolution enhancement of dexibuprofen with hydroxypropylbetacyclodextrin (HPβCD) and poloxamers (188/407) inclusion complexes: preparation and in vitro characterization. Polymers, 14(3). 10.3390/POLYM14030579.

Newa, M., Bhandari, K. H., Li, D. X., Kwon, T. H., Kim, J. A., Yoo, B. K., Woo, J. S., Lyoo, W. S., Yong, C. S., & Choi, H. G. (2007). Preparation, characterization, and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. International Journal of Pharmaceutics, 343(1–2), 228–237. 10.1016/J.IJPHARM.2007.05.031.

Pai, R., Kohli, K., Jain, G., & Srivastava, B. (2011). In vitro and in vivo evaluations of ketoprofen extended release pellets prepared using powder layering technique in a rotary centrifugal granulator. Archives of Pharmacal Research, 34(7), 1135–1142. 10.1007/S12272-011-0711-1.

Pandey, K., Shettar, V., & Kale, T. (2023). Efficacy of transdermal ketoprofen patch in comparison to transdermal diclofenac patch in postoperative analgesia for orthodontic extractions: a randomized split-mouth study. Cureus, 15(4). doi.org/10.7759/CUREUS.37732.

Patel, K., Shah, S., & Patel, J. (2022). Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: a comprehensive review. DARU Journal of Pharmaceutical Sciences, 30(1), 165. 10.1007/S40199-022-00440-0.

Pearnchob, N., Siepmann, J., & Bodmeier, R. (2003). Pharmaceutical applications of shellac: moisture-protective and taste-masking coatings and extended-release matrix tablets. Drug Development and Industrial Pharmacy, 29(8), 925–938. 10.1081/DDC-120024188.

Sabegh, M. A., Rajaei, H., Esmaeilzadeh, F., & Lashkarbolooki, M. (2012). Solubility of ketoprofen in supercritical carbon dioxide. The Journal of Supercritical Fluids, 72, 191–197. 10.1016/J.SUPFLU.2012.08.008.

Sarzi- Puttini, P., Atzeni, F., Lanata, L., Bagnasco, M., Colombo, M., Fischer, F., & D’Imporzano, M. (2010). Pain and ketoprofen: what is its role in clinical practice?. Reumatismo, 62(3). https://doi.org/10.4081/REUMATISMO.2010.172

Thibault, M. P., Tremblay, É., Wallace, J. L., & Beaulieu, J. F. (2019). Effect of ketoprofen and ATB-352 on the immature human intestine: Identification of Responders and Non-responders. Journal of Pediatric Gastroenterology and Nutrition, 68(5), 623. 10.1097/MPG.0000000000002308.

van der Merwe, J., Steenekamp, J., Steyn, D., & Hamman, J. (2020). The role of functional excipients in solid oral dosage forms to overcome poor drug dissolution and bioavailability. Pharmaceutics, 12(5). 10.3390/PHARMACEUTICS12050393.

Velásquez, G., Cruz, L. A., & Espinoza, M. (2014). Ketoprofen is more effective than diclofenac after oral surgery when used as a preemptive analgesic: a pilot study. Journal of Oral & Facial Pain and Headache, 28(2), 153–158. 10.11607/OFPH.1200.

Verano Naranjo, L., Cejudo Bastante, C., Casas Cardoso, L., Mantell Serrano, C., & Martínez de la Ossa Fernández, E. J. (2021). Supercritical impregnation of ketoprofen into polylactic acid for biomedical application: analysis and modeling of the release kinetics. Polymers, 13(12). 10.3390/POLYM13121982.

Vueba, M. L., Batista De Carvalho, L. A. E., Veiga, F., Sousa, J. J., & Pina, M. E. (2013). In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures. Drug Development and Industrial Pharmacy, 39(11), 1651–1662. 10.3109/03639045.2012.729146.

Wakamatsu, J., Sato, K., Uryu, K., & Maru, I. (2021). Clinical demonstrations of controlled-release tablets constructed by the combined usage of shellac and hydroxypropyl methylcellulose. Future Pharmacology 2021, Vol. 1, Pages 48-59, 1(1), 48–59. 10.3390/FUTUREPHARMACOL1010005.

Wasilewska, K., & Winnicka, K. (2019). Ethylcellulose–a pharmaceutical excipient with multidirectional application in drug dosage forms development. Materials, 12(20). https://doi.org/10.3390/MA12203386

Zeng, X., Zhang, Y., Kwong, J. S. W., Zhang, C., Li, S., Sun, F., Niu, Y., & Du, L. (2015). The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. Journal of Evidence-Based Medicine, 8(1), 2–10. 10.1111/JEBM.12141

Zhang, X., Han, Y., Huang, W., Jin, M., & Gao, Z. (2021). The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharmaceutica Sinica. B, 11(7), 1789. 10.1016/J.APSB.2020.09.013.

DOI: https://doi.org/10.20961/jpscr.v9i1.80292

Refbacks

  • There are currently no refbacks.